Nature's Sunshine Products (NATR) AI Stock Analysis

• Market Cap: $357.43M
• Dividend Yield: N/A
• Average Volume (3M): 148.36K
• Price to Earnings (P/E): 25.2
• Beta (1Y): 0.46
• Revenue Growth: 6.62%
• EPS Growth: -7.85%
• Country: US
• Employees: 819
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Packaged Foods
• EPS (TTM): 0.36
• Shares Outstanding: 17,495,564
• 10 Day Avg. Volume: 149,443
• 30 Day Avg. Volume: 148,361
• PEG Ratio: -0.74
• Price to Book (P/B): 1.76
• Price to Sales (P/S): 0.60
• P/FCF Ratio: 19.05
• Enterprise Value/Market Cap: 0.57
• Enterprise Value/Revenue: 0.43
• Enterprise Value/Gross Profit: 0.60
• Enterprise Value/Ebitda: 4.88
• 1Y Price Target: $22.50
• Price Target Upside: 10.13% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2
• EPS Forecast (FY): 0.98
• Revenue Forecast (FY): $467.12M

• Rating: 73 Outperform
• Price Target: $23.00 ▲(12.58% Upside)

Nature's Sunshine Products scores well due to strong financial performance and positive earnings call highlights, including raised guidance and robust regional growth. However, technical indicators suggest the stock is overbought, and the valuation is moderate, which tempers the overall score.

Positive Factors

Revenue Growth

The record-breaking quarterly revenue growth indicates strong market demand and effective sales strategies, supporting long-term business expansion.

Digital Sales Expansion

Significant growth in digital sales reflects successful adaptation to e-commerce trends, enhancing future revenue streams and market reach.

Strong Cash Position

A strong cash position with no debt enhances financial flexibility, enabling strategic investments and resilience against economic fluctuations.

Negative Factors

Tariff Impact

Tariffs could pressure margins, potentially affecting profitability. This may require strategic adjustments to maintain margin sustainability.

Q4 Revenue Timing

Revenue timing shifts may lead to flat or reduced Q4 growth, impacting short-term financial performance and investor expectations.

Earnings Volatility

While profitability has improved, earnings volatility remains a concern, potentially affecting investor confidence and long-term planning.

Nature's Sunshine Products Business Overview & Revenue Model

Company Description

Nature's Sunshine Products, Inc., a natural health and wellness company, primarily manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. The company was founded in 1972 and is headquartered in Lehi, Utah.

How the Company Makes Money

Nature's Sunshine Products generates revenue through several key streams, primarily by selling its health and wellness products directly to consumers and through a network of independent distributors. This multi-level marketing (MLM) model allows individuals to earn commissions not only on their sales but also on the sales made by their recruited distributors, fostering a community-driven sales strategy. The company also benefits from e-commerce sales through its website, providing a direct-to-consumer channel. Additionally, partnerships with various health and wellness retailers enhance its market reach. The company's ongoing investment in product innovation and marketing further drives sales growth and brand loyalty.

Nature's Sunshine Products Financial Statement Overview

Summary

Nature's Sunshine Products demonstrates solid financial health with consistent revenue growth, strong profitability margins, and effective cash flow management. The balance sheet is stable with low leverage, positioning the company well for future growth opportunities.

Income Statement

Nature's Sunshine Products shows a steady revenue growth rate of 2.98% TTM, with a strong gross profit margin of 71.91%. The net profit margin has improved to 4.36% TTM, indicating enhanced profitability. However, the EBIT and EBITDA margins, while positive, suggest room for operational efficiency improvements.

Balance Sheet

The company maintains a low debt-to-equity ratio of 0.086 TTM, reflecting prudent financial management. Return on Equity (ROE) is at 9.42% TTM, showing a decent return for shareholders. The equity ratio is strong, indicating a solid capital structure with a good proportion of equity financing.

Cash Flow

Free cash flow growth is robust at 39.84% TTM, demonstrating strong cash generation capabilities. The operating cash flow to net income ratio is 0.32, indicating healthy cash flow relative to net income. The free cash flow to net income ratio of 0.88 suggests effective conversion of earnings into cash.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	474.54M	454.36M	445.32M	421.91M	444.08M	385.20M
Gross Profit	343.01M	324.69M	321.13M	299.76M	328.62M	283.93M
EBITDA	41.96M	32.79M	32.09M	31.15M	43.23M	33.67M
Net Income	15.09M	7.70M	15.08M	-390.00K	28.85M	21.34M
Balance Sheet
Total Assets	264.81M	240.85M	249.77M	229.78M	258.87M	249.50M
Cash, Cash Equivalents and Short-Term Investments	95.55M	84.70M	82.37M	60.03M	86.18M	92.07M
Total Debt	14.29M	14.20M	14.92M	19.18M	22.99M	26.33M
Total Liabilities	98.10M	79.86M	90.23M	82.73M	97.47M	92.26M
Stockholders Equity	160.50M	155.31M	154.06M	142.91M	158.20M	155.39M
Cash Flow
Free Cash Flow	31.27M	14.33M	30.75M	-6.92M	27.94M	32.75M
Operating Cash Flow	37.61M	25.30M	41.23M	710.00K	34.61M	37.66M
Investing Cash Flow	-6.34M	-10.97M	-10.48M	-7.63M	-6.61M	-4.91M
Financing Cash Flow	-15.82M	-9.90M	-7.96M	-16.25M	-31.72M	3.88M

Nature's Sunshine Products Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 20.43
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NATR, the sentiment is Positive. The current price of 20.43 is above the 20-day moving average (MA) of 18.30, above the 50-day MA of 16.34, and above the 200-day MA of 14.93, indicating a bullish trend. The MACD of 1.49 indicates Negative momentum. The RSI at 65.87 is Neutral, neither overbought nor oversold. The STOCH value of 54.17 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NATR.

Nature's Sunshine Products Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
MAMA	76 Outperform	$462.09M	99.74	17.44%	―	19.34%	-12.64%
NATR	73 Outperform	$357.43M	25.18	9.52%	―	6.62%	-7.85%
FTLF	71 Outperform	$174.02M	26.64	17.77%	―	12.44%	-20.33%
LFVN	66 Neutral	$85.86M	8.78	33.31%	2.33%	16.77%	143.30%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
LSF	46 Neutral	$27.78M	―	-14.63%	―	17.73%	-34.71%
HAIN	38 Underperform	$96.91M	-0.18	-75.51%	―	-10.13%	-532.32%

Nature's Sunshine Products Corporate Events

Nature’s Sunshine Products: Record Earnings and Positive Outlook

Nature’s Sunshine Products Shines in Latest Earnings Call

Nature’s Sunshine Reports Strong Q3 2025 Results

Nature’s Sunshine Products, Inc., a prominent player in the natural health and wellness industry, specializes in manufacturing and distributing high-quality herbal and nutritional supplements across more than 40 countries. In its latest earnings report for the third quarter of 2025, the company announced a significant increase in net sales and profitability. Net sales rose by 12% to $128.3 million, while the GAAP earnings per share saw a 30% increase to $0.30. The adjusted EBITDA also experienced a substantial rise of 42%, reaching $15.2 million.

Nature’s Sunshine Products Explores Cognitive Benefits with New Study

Nature’s Sunshine Products is conducting a study titled ‘Evaluation of Acute Cognitive Effects of Brain Edge on Healthy Volunteers.’ The study aims to assess the cognitive benefits of Brain Edge, a dietary supplement, on healthy adults. This research is significant as it explores potential enhancements in cognitive health and mood.

Nature’s Sunshine Appoints Kenneth Romanzi as New CEO

On October 15, 2025, Nature’s Sunshine Products announced the appointment of Kenneth Romanzi as the new Chief Executive Officer, effective October 29, 2025, succeeding Terrence O. Moorehead. Romanzi, with over 40 years of experience in the consumer-packaged goods industry, is expected to drive growth and innovation for the company, leveraging his extensive leadership background. This leadership change is part of the company’s strategic efforts to enhance its market position and accelerate its growth trajectory, aiming to expand its digital and omnichannel offerings globally.

The most recent analyst rating on (NATR) stock is a Hold with a $16.50 price target. To see the full list of analyst forecasts on Nature’s Sunshine Products stock, see the NATR Stock Forecast page.